Article Text
Abstract
Mitochondrial replacement techniques (MRTs) are a new group of biotechnologies that aim to aid women whose eggs have disease-causing deleteriously mutated mitochondria to have genetically related healthy children. These techniques have also been used to aid women with poor oocyte quality and poor embryonic development, to have genetically related children. Remarkably, MRTs create humans with DNA from three sources: nuclear DNA from the intending mother and father, and mitochondrial DNA from the egg donor. In a recent publication Françoise Baylis argued that MRTs are detrimental for genealogical research via mitochondrial DNA because they would obscure the lines of individual descent. In this paper, I argue that MRTs do not obscure genealogical research, but rather that MRT-conceived children can have two mitochondrial lineages. I argue for this position by showing that MRTs are reproductive in nature and, thus, they create genealogy.
- fertilization in vitro
- genetic engineering
- genetic therapy
- gene transfer techniques
- in vitro techniques
Data availability statement
No data are available.
Statistics from Altmetric.com
Data availability statement
No data are available.
Footnotes
Twitter @CPalaciosG
Contributors I am the sole author of the paper, and its guarantor.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Lesbian motherhood and mitochondrial replacement techniques: reproductive freedom and genetic kinship
- Does egg donation for mitochondrial replacement techniques generate parental responsibilities?
- Mitochondrial replacement techniques for treating infertility
- De novo mtDNA point mutations are common and have a low recurrence risk
- Nuclear transfer to prevent maternal transmission of mitochondrial DNA disease
- Mitochondrial donation and ‘the right to know’
- The need for donor consent in mitochondrial replacement
- ‘Recombining’ biological motherhoods. Towards two ‘complete’ biological mothers
- Mitochondria
- Information for genetic management of mtDNA disease: sampling pathogenic mtDNA mutants in the human germline and in placenta